Education lowers dose detecting pulmonary emboli
Collaborative educational seminars reduce the number of CT scans and the radiation dose delivered to emergency department patients suspected of pulmonary emboli, according to a study from a New York medical center.
Collaborative educational seminars reduce the number of CT scans and the radiation dose delivered to emergency department patients suspected of pulmonary emboli, according to a study from a New York medical center.
At Montefiore Medical Center in the Bronx, collaborative educational seminars were held among the radiology, nuclear medicine, and emergency medicine departments about the radiation dose and accuracy of ventilation perfusion scanning (V/Q) and CT pulmonary angiography (CTPA). In addition, emergency department patients with a clinical suspicion of PE underwent chest radiography. If the x-ray was normal, V/Q was recommended, otherwise CTPA was the test of choice.
The number of CT pulmonary angiography tests dropped from 1234 in 2006 to 920 in 2007, according to the study. The number of V/Q scans increased from 745 in 2006 to 1216 in 2007. The radiation was reduced by 20% from 8 mSv in 2006 to 6.4 mSv in 2007, according to the researchers. Results were published in the February issue of the American Journal of Roentgenology.
Where Things Stand with the Radiologist Shortage
June 18th 2025A new report conveys the cumulative impact of ongoing challenges with radiologist residency positions, reimbursement, post-COVID-19 attrition rates and the aging of the population upon the persistent shortage of radiologists in the United States.
How to Successfully Launch a CCTA Program at Your Hospital or Practice
June 11th 2025Emphasizing increasing recognition of the capability of coronary computed tomography angiography (CCTA) for the evaluation of acute and stable chest pain, this author defuses common misperceptions and reviews key considerations for implementation of a CCTA program.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Mammography AI Platform for Five-Year Breast Cancer Risk Prediction Gets FDA De Novo Authorization
June 2nd 2025Through AI recognition of subtle patterns in breast tissue on screening mammograms, the Clairity Breast software reportedly provides validated risk scoring for predicting one’s five-year risk of breast cancer.
